Raleigh Lindsay, Ha Rich, Hill Charles
Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University, Stanford, CA, USA.
Department of Cardiothoracic Surgery, Stanford University, Stanford, CA, USA.
Semin Cardiothorac Vasc Anesth. 2015 Dec;19(4):342-52. doi: 10.1177/1089253215607065. Epub 2015 Sep 24.
The use of extracorporeal membrane oxygenation therapy (ECMO) in cardiac critical care has steadily increased over the past decade. Significant improvements in the technology associated with ECMO have propagated this recent resurgence and contributed to improved patient outcomes in the fields of cardiac and transplant (heart and lung) surgery. Specifically, ECMO is being increasingly utilized as a bridge to heart and lung transplantation, as well as to ventricular assist device placement. ECMO is also employed during the administration of cardiopulmonary resuscitation, known as extracorporeal life support. In this review, we examine the recent literature regarding the applications of ECMO and also describe emerging topics involving current ECMO management strategies.
在过去十年中，体外膜肺氧合治疗（ECMO）在心脏重症监护中的应用稳步增加。与ECMO相关的技术取得了重大进展，推动了这一疗法最近的复兴，并有助于改善心脏和移植（心脏和肺）手术领域的患者预后。具体而言，ECMO越来越多地被用作心脏和肺移植以及心室辅助装置植入的桥梁。ECMO也用于心肺复苏期间，即所谓的体外生命支持。在本综述中，我们研究了关于ECMO应用的最新文献，并描述了涉及当前ECMO管理策略的新兴话题。
